Wealthcare Advisory Partners LLC Ionis Pharmaceuticals Inc Transaction History

Wealthcare Advisory Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$38.5 - $47.13 $177,600 - $217,410	4,613 New	4,613 $209,000
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $250,610 - $302,989	-7,472 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $9,084 - $12,426	263 Added 3.65%	7,472 $298,000
Q1 2021 Apr 30, 2021	BUY	$42.51 - $63.78 $110,653 - $166,019	2,603 Added 56.51%	7,209 $324,000
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $208,651 - $277,603	4,606 New	4,606 $260,000
Q2 2020 Jul 29, 2020	SELL	$46.85 - $61.05 $2,576 - $3,357	-55 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$59.06 - $72.15 $3,248 - $3,968	55 New	55 $3,000
Q2 2019 Jul 30, 2019	SELL	$62.09 - $86.14 $6,209 - $8,614	-100 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $4,408 - $5,505	-100 Reduced 50.0%	100 $4,000
Q3 2017 Nov 15, 2017	BUY	$45.56 - $59.57 $9,112 - $11,914	200	200 $10,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.